Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
PC 360
Article
Trump executive order presents challenges for workers’ comp, auto insurers
Workers' Comp
Article
Accelerating Recovery and Return to Work: The Case for Case Management
In workers’ compensation, one of the most effective ways to reduce claim duration and associated costs is to get injured employees back to work—saf
Workers' Comp
Article
Turning Regulatory Obstacles into Strategy Advantages Using Informed Decision-Making in Workers’ Comp & Auto Casualty
Following our examination of President Trump's health care executive order and its implications for workers' compensation and auto payers in
WorkcompWire
Article
Ripple Effect: Potential Impacts of Tariffs and Proposed Medicaid Cuts on Workers’ Comp
Workers' Comp
Article
Strengthening Return-to-Work Outcomes: A Guide to Vocational Case Management for Claims Professionals
When a workplace injury disrupts an employee’s ability to work, the path back to productivity can be complex.
Insurance Journal
Article
A True Alternative to Opioids for Workers’ Comp? Questions Remain
Enlyte’s Nikki Wilson weighs in on suzetrigine as a potential opioid alternative in workers’ comp.